April 23, 2010 at 17:45 PM EDT
Innovation Helps Irish Drugmaker Soar Above The Competition
It's easy to see why so much recent attention at Warner Chilcott has centered on the Irish drugmaker's buyout of Procter & Gamble's global branded drug business. The $3.1 billion deal, which was announced in August and began contributing to results last quarter, is already having a huge impact on Warner Chilcott's (WCRX) financials. The company's sales nearly tripled last quarter, thanks mainly to added business from the P&G (PG) lineup, which
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here